The "you know whos" seem to have gotten a heads up on the coronavirus! Israeli vaccines 2/27/20

HUGE BREAKING NEWS: Israeli Researchers on Cusp of Creating Coronavirus Vaccine — Could be Ready in a Few Weeks and Available in 90 Days

Israeli researchers at the Galilee Research Institute say they are just a few weeks away from the first vaccine of the coronavirus.
If all goes well, the vaccine could be available in 90 days.
MUST READ — From the Galilee Research Institute website:

https://www.thegatewaypundit.com/2020/02/huge-breaking-news-israeli-researchers-on-cusp-of-creating-coronavirus-vaccine-could-be-ready-in-a-few-weeks-and-available-in-90-days/

Breakthrough From Israel’s MIGAL Research Institute in Development of Corona virus (COVID-19) Vaccine

27 February, 2020
After 4 years of research funded by Israel’s Ministry of Science & Technology, MIGAL’s researchers have developed an effective vaccine against avian coronavirus Infectious Bronchitis Virus (IBV), to be adapted soon and create a human vaccine against COVID-19


Israel’s Minister of Science and Technology, Mr. Ofir Akunis, commented: “Congratulations to MIGAL on this exciting breakthrough. I am confident that there will be further rapid progress, enabling us to provide a needed response to the grave global COVID-19 threat.” Minister Akunis has instructed the Director General of the Ministry of Science and Technology to fast-track all approval processes with the goal of bringing the human vaccine to market as quickly as possible.

After 4 years of multi-disciplinary research funded by Israel’s Ministry of Science and Technology in cooperation with Israel’s Ministry of Agriculture, MIGAL has achieved a scientific breakthrough that will lead to the rapid creation of a vaccine against Coronavirus. This possibility was identified as a by-product of MIGAL’s development of a vaccine against IBV (Infectious Bronchitis Virus), a disease affecting poultry, whose effectiveness has been proven in pre-clinical trials carried out at the Volcani Institute. MIGAL has now made required genetic adjustments to adapt the vaccine to COVID-19, the human strain of coronavirus, and is working to achieve the safety approvals that will enable in-vivo testing, enable the initiation of production of a vaccine to counter the Coronavirus epidemic currently spreading throughout the world, which so far has claimed 2,666 lives.

From research conducted at MIGAL, it has been found that the poultry coronavirus has high genetic similarity to the human COVID-19, and that it uses the same infection mechanism, a fact that increases the likelihood of achieving an effective human vaccine in a very short period of time.

Commenting on the news, David Zigdon, CEO of MIGAL GALILEE RESEARCH INSTITUTE, said, “Given the urgent global need for a human coronavirus vaccine, we are doing everything we can to accelerate development. Our goal is to produce the vaccine during the next 8-10 weeks, and to achieve safety approval in 90 days. This will be an oral vaccine, making it particularly accessible to the general public. We are currently in intensive discussions with potential partners that can help accelerate the in-human trials phase and expedite the completion final product development and regulatory activities.”

http://www.migal.org.il/Migal/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=1144&PID=0&IID=8138